Pender Ventures
Vancouver, BC
Investment Thesis
Pender Ventures invests in health tech and B2B software companies at the inflection point between commercialization and scale, focusing on validated products with proven product-market fit, strong unit economics, and meaningful customer impact. The fund prioritizes thesis-driven investing on company fundamentals, with a sweet spot in Series A, and maintains a commitment to backing diverse founding teams with best-in-class track records of positive social impact.
Focus Areas
Investment Stage
Growth
Investment Signals
GeographyCanada-focused
ProvincesBC, AB, ON, QC
RoleBoth
Revenue Stagetraction required
Impact MandateYes
Business ModelsB2B, SaaS
Sample Portfolio Companies
Copperleaf ($1B M&A - CVCA 2025 Deal of the Year)
Clarius
DistillerSR
Jane Software
Traction Rec
Veritree
Science & Humans
InsideDesk
Management Team
M
Maria Pacella
Managing Partner
C
Cheri Corbett
Partner
M
Meryeme Lahmami
Principal
T
Tony Rautava
Manager
L
Lynn Frazer
Head of People Strategy
What Makes Us Unique
Best-in-class track record of diverse teams with positive social impact. Canadian Health Tech Funding & Trends Report. HealthTech Ignite conferences.
AUM & Sources
Est. US$90M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.